Evidence map›Paper›PMID 36296322›Full record

ArticleMicroorganisms2022

Manorama Kumari, Vaishali L Dasriya, Basavaprabhu H Nataraj, Ravinder Nagpal, Pradip V Behare

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Nutrients · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Oral Administration ofAntioxidants (Basel, Switzerland) · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Manorama KumariTechnofunctional Starter Lab., National Collection of Dairy Cultures (NCDC), Dairy Microbiology Division, National Dairy Research Institute, Karnal 132001, Haryana, India.
Vaishali L DasriyaTechnofunctional Starter Lab., National Collection of Dairy Cultures (NCDC), Dairy Microbiology Division, National Dairy Research Institute, Karnal 132001, Haryana, India.
Basavaprabhu H NatarajTechnofunctional Starter Lab., National Collection of Dairy Cultures (NCDC), Dairy Microbiology Division, National Dairy Research Institute, Karnal 132001, Haryana, India.ORCID 0000-0003-4319-264X
Ravinder NagpalDepartment of Nutrition and Integrative Physiology, Florida State University, Tallahassee, FL 32306, USA.ORCID 0000-0002-4250-1749
Pradip V BehareTechnofunctional Starter Lab., National Collection of Dairy Cultures (NCDC), Dairy Microbiology Division, National Dairy Research Institute, Karnal 132001, Haryana, India.
National Dairy Research Institute · INFlorida State University · US

Funding

Ministry of Food Processing Industries, Government of India Q-11/40/2018-R&D
6 · The paper itself

Abstract

This study aimed to investigate the protective effect of a novel exopolysaccharide EPSRam12, produced by

Indexed as

anti-inflammatoryantioxidantexopolysaccharidegut microbiotamicrobiota–gut–brain axis

Identifiers

PMID36296322
PMCPMC9611687
OpenAlexW4306761606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.